iMReC research team is focused on creating the next generation of small molecules and peptides medicines designed to bring hope to patients fighting immune-related diseases. Our strategic focus on restoring/ enhancing the functions of the immune system is driven by the recognition that the immune system plays a central role in development and control of many diseases, which are on the rise.
Our aim is to have significant impact on the quality of life of millions of individuals by developing medicines for diseases with high-unmet medical needs. Our research efforts are focused on multiple sclerosis and psoriasis in the autoimmunity filed, colon and pancreatic cancers in malignancy field.
